TipRanks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market
ONCY
Oncolytics Biotech
RESEARCH TOOLSreports
Want to see ONCY full AI Analyst Report?

Oncolytics Biotech (ONCY) Income Statement

1,667 Followers

Oncolytics Biotech Income Statement

Last quarter (Q2 2026), Oncolytics Biotech's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Oncolytics Biotech's net income was C$-9.44M. See Oncolytics Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 28.73MC$ 25.54MC$ 25.47MC$ 19.84MC$ 26.23M
Depreciation and Amortization
C$ 70.00KC$ 87.00KC$ 303.78KC$ 288.83KC$ 452.00K
EBITDA
C$ -28.66MC$ -25.45MC$ -25.17MC$ -19.55MC$ -25.78M
Operating Income
C$ -28.73MC$ -25.54MC$ -25.47MC$ -19.84MC$ -26.23M
Other Income/Expenses
C$ 45.00KC$ 2.84MC$ 4.63MC$ 1.60MC$ -20.05K
Pretax Income
C$ -28.68MC$ -22.70MC$ -20.85MC$ -18.24MC$ -26.25M
Net Income
C$ -28.76MC$ -22.79MC$ -20.92MC$ -18.30MC$ -26.30M
Per Share Metrics
Basic EPS
C$ -0.41C$ -0.30C$ -0.41C$ -0.44C$ -0.49
Diluted EPS
C$ -0.41C$ -0.30C$ -0.41C$ -0.44C$ -0.49
Weighted Average Shares Outstanding
 95.86M 76.48M 67.62M 58.03M 53.51M
Weighted Average Shares Outstanding (Diluted)
 95.86M 76.48M 67.62M 58.03M 53.51M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History